NVIV - InVivo Therapeutics Holdings Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.7400
0.0000 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close0.7400
Open0.7307
Bid0.7002 x 2900
Ask0.9000 x 900
Day's Range0.7301 - 0.8100
52 Week Range0.6500 - 4.7500
Volume50,984
Avg. Volume74,731
Market Cap6.89M
Beta (3Y Monthly)1.25
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals21 days ago

    Bob Langer-founded device-maker InVivo starts new trial after patient deaths

    Nearly two years after halting multiple clinical trials due to the deaths of three participants for what's described as unrelated reasons, Kendall Square medical device maker InVivo Therapeutics Corp. has launched its first new trial of an implant it believes could help heal spinal cord injuries.

  • Associated Press7 months ago

    InVivo: 3Q Earnings Snapshot

    On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 42 cents. In the final minutes of trading on Thursday, the company's shares hit $2.09. A year ago, they were trading ...

  • Associated Press10 months ago

    InVivo: 2Q Earnings Snapshot

    The Cambridge, Massachusetts-based company said it had a loss of $7.48 per share. In the final minutes of trading on Tuesday, the company's shares hit $2.08. A year ago, they were trading at $50. _____ ...